Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 03-Apr-24 5:06 PM View:  | Vyne Therapeutics Inc. (VYNE) | 01-Apr-24 | Payment of Exercise | 157 | $3.08 | $483.56 | (< 1%) 133.9K to 133.74K | |
| 03-Jan-24 5:21 PM View: | Vyne Therapeutics Inc. (VYNE) | 02-Jan-24 | Payment of Exercise | 157 | $2.28 | $357.96 | (< 1%) 134.06K to 133.9K | |
| 03-Jan-24 5:21 PM View: | Vyne Therapeutics Inc. (VYNE) | 01-Jan-24 | Grant | 62,500 | -- | -- | 87% 71.56K to 134.06K | |
| 15-Dec-23 5:10 PM View: | Vyne Therapeutics Inc. (VYNE) | 13-Dec-23 | Grant | 62,500 | -- | -- | 690% 9.05K to 71.56K | |
| 04-Oct-23 4:23 PM View: | Vyne Therapeutics Inc. (VYNE) | 02-Oct-23 | Payment of Exercise | 1,184 | $3.83 | $4,534.72 | (12%) 10.24K to 9.05K | |
| 05-Jul-23 4:34 PM View: | Vyne Therapeutics Inc. (VYNE) | 30-Jun-23 | Payment of Exercise | 151 | $4.10 | $619.10 | (1%) 10.39K to 10.24K | |
| 04-Apr-23 5:05 PM View: | Vyne Therapeutics Inc. (VYNE) | 31-Mar-23 | Payment of Exercise | 480 | $3.08 | $1,478.40 | (4%) 10.87K to 10.39K | |
| 04-Jan-23 5:09 PM View: | Vyne Therapeutics Inc. (VYNE) | 31-Dec-22 | Payment of Exercise | 1,720 | $0.15 | $258.00 | (< 1%) 221.97K to 220.25K | |
| 04-Oct-22 5:05 PM View: | Vyne Therapeutics Inc. (VYNE) | 30-Sep-22 | Payment of Exercise | 1,719 | $0.22 | $383.34 | (< 1%) 223.69K to 221.97K | |
| 05-Jul-22 5:01 PM View: | Vyne Therapeutics Inc. (VYNE) | 30-Jun-22 | Payment of Exercise | 1,719 | $0.39 | $668.69 | (< 1%) 225.41K to 223.69K | |
| 04-Apr-22 5:09 PM View: | Vyne Therapeutics Inc. (VYNE) | 31-Mar-22 | Payment of Exercise | 3,469 | $0.65 | $2,254.85 | (2%) 228.88K to 225.41K | |
| 18-Mar-22 5:10 PM View: | Vyne Therapeutics Inc. (VYNE) | 17-Mar-22 | Grant | 75,000 | -- | -- | 49% 153.88K to 228.88K | |
| 04-Jan-22 4:40 PM View: | Vyne Therapeutics Inc. (VYNE) | 31-Dec-21 | Payment of Exercise | 1,250 | $1.02 | $1,275.00 | (< 1%) 155.13K to 153.88K | (17%) |
| 01-Oct-21 5:12 PM View: | Vyne Therapeutics Inc. (VYNE) | 30-Sep-21 | Payment of Exercise | 1,480 | $1.39 | $2,057.20 | (< 1%) 156.61K to 155.13K | (< 1%) |
| 03-Sep-21 5:34 PM View: | Vyne Therapeutics Inc. (VYNE) | 02-Sep-21 | Grant | 60,859 | -- | -- | 64% 95.75K to 156.61K | |
| 02-Jul-21 4:36 PM View: | Vyne Therapeutics Inc. (VYNE) | 30-Jun-21 | Payment of Exercise | 3,083 | $3.51 | $10,821.30 | (3%) 98.83K to 95.75K | 1% |
| 02-Apr-21 12:14 PM View: | Vyne Therapeutics Inc. (VYNE) | 31-Mar-21 | Payment of Exercise | 1,945 | $6.84 | $13,303.80 | (2%) 100.78K to 98.83K | (1%) |
| 24-Feb-21 4:39 PM View: | Vyne Therapeutics Inc. (VYNE) | 22-Feb-21 | Grant | 29,213 | -- | -- | 41% 71.56K to 100.78K | |
| 05-Jan-21 4:32 PM View: | Vyne Therapeutics Inc. (VYNE) | 31-Dec-20 | Payment of Exercise | 2,378 | $1.58 | $3,757.24 | (< 1%) 288.64K to 286.26K | 12% |
| 02-Oct-20 4:32 PM View: | Vyne Therapeutics Inc. (VYNE) | 30-Sep-20 | Payment of Exercise | 2,378 | $1.66 | $3,947.48 | (< 1%) 291.02K to 288.64K | (6%) |
| 02-Jul-20 4:25 PM View: | Vyne Therapeutics Inc. (VYNE) | 30-Jun-20 | Payment of Exercise | 2,378 | $1.73 | $4,113.94 | (< 1%) 293.4K to 291.02K | (3%) |
| 08-May-20 5:54 PM View: | Vyne Therapeutics Inc. (VYNE) | 06-May-20 | Grant | 112,500 | -- | -- | 62% 180.9K to 293.4K | |
| 07-Apr-20 5:22 PM View: | Vyne Therapeutics Inc. (VYNE) | 06-Apr-20 | Payment of Exercise | 3,763 | $1.40 | $5,268.20 | (2%) 184.66K to 180.9K | (27%) |
| 07-Apr-20 5:22 PM View: | Vyne Therapeutics Inc. (VYNE) | 03-Apr-20 | Grant | 125,212 | -- | -- | 211% 59.45K to 184.66K | |
| 02-Apr-20 4:41 PM View: | Vyne Therapeutics Inc. (VYNE) | 31-Mar-20 | Payment of Exercise | 1,940 | $2.68 | $5,199.20 | (3%) 61.39K to 59.45K | 34% |
| 11-Mar-20 5:41 PM View: | Foamix Pharmaceuticals Ltd. (FOMX) | 09-Mar-20 | Disposition | 103,636 | -- | -- | (100%) 103.64K to 0 | |
| 11-Mar-20 5:57 PM View: | Vyne Therapeutics Inc. (VYNE) | 09-Mar-20 | Grant | 61,392 | -- | -- | 100% 0 to 61.39K | |
| 24-Feb-20 6:39 PM View: | Foamix Pharmaceuticals Ltd. (FOMX) | 24-Feb-20 | Grant | 41,299 | -- | -- | 66% 62.34K to 103.64K | |
| 03-Jan-20 5:23 PM View: | Foamix Pharmaceuticals Ltd. (FOMX) | 31-Dec-19 | Payment of Exercise | 514 | $3.28 | $1,685.92 | (< 1%) 62.85K to 62.34K | |
| 02-Oct-19 4:20 PM View: | Foamix Pharmaceuticals Ltd. (FOMX) | 30-Sep-19 | Payment of Exercise | 673 | $3.07 | $2,066.11 | (1%) 63.52K to 62.85K | |
| 03-Jul-19 4:26 PM View: | Foamix Pharmaceuticals Ltd. (FOMX) | 01-Jul-19 | Market Sale | 951 | $2.35 | $2,234.85 | (1%) 64.47K to 63.52K | (13%) |
| 03-Apr-19 4:38 PM View: | Foamix Pharmaceuticals Ltd. (FOMX) | 01-Apr-19 | Market Sale | 1,696 | $3.75 | $6,360.00 | (3%) 66.17K to 64.47K | (8%) |
| 03-Jan-19 4:08 PM View: | Foamix Pharmaceuticals Ltd. (FOMX) | 01-Jan-19 | Grant | 32,569 | -- | -- | 97% 33.6K to 66.17K | |
| 13-Nov-18 6:16 AM View: | Foamix Pharmaceuticals Ltd. (FOMX) | 08-Nov-18 | Market Sale | 683 | $4.58 | $3,128.14 | (2%) 34.28K to 33.6K | 22% |
| 09-Aug-18 4:05 PM View: | Foamix Pharmaceuticals Ltd. (FOMX) | 08-Aug-18 | Market Sale | 2,715 | $5.68 | $15,421.20 | (7%) 37.0K to 34.28K | 37% |
| 28-Feb-18 4:12 PM View: | Foamix Pharmaceuticals Ltd. (FOMX) | 27-Feb-18 | Grant | 10,000 | -- | -- | 37% 27.0K to 37.0K |